Key Events This Week
Apr 20: Downgrade to Sell rating announced
Apr 21: Stock declines amid downgrade concerns
Apr 23: Valuation shifts to very attractive despite price drop
Apr 24: Modest recovery with slight price gain

Innova Captab Ltd Valuation Shifts to Very Attractive Amid Sector Pressure
2026-04-23 08:01:44Innova Captab Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite recent price pressures and sector headwinds. This change reflects evolving investor sentiment and a reassessment of the company’s price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, offering a fresh perspective on its market appeal within the Pharmaceuticals & Biotechnology sector.
Read full news article
Innova Captab Ltd Downgraded to Sell Amid Valuation and Growth Concerns
2026-04-21 08:50:33Innova Captab Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 Apr 2026. This change reflects a nuanced assessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive financial indicators, concerns over long-term growth and market underperformance have weighed heavily on the outlook.
Read full news articleInnova Captab Ltd Gains 7.34%: 4 Key Factors Driving the Weekly Rally
2026-04-18 10:03:36
Key Events This Week
13 Apr: Technical momentum shifts to mildly bearish with cautious optimism
15 Apr: Intraday high surge of 8.29% to Rs.751.45
16 Apr: Valuation metrics improve amid market volatility
17 Apr: Week closes at Rs.740.50, up 7.34% for the week

Innova Captab Ltd Valuation Improves Amid Market Volatility
2026-04-16 08:01:50Innova Captab Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved investor sentiment despite a challenging pharmaceutical sector backdrop. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now position it favourably against peers, signalling a potential re-rating opportunity for investors seeking exposure in the pharmaceuticals and biotechnology space.
Read full news article
Innova Captab Ltd Surges 8.29% to Day's High of Rs 751.45 — Outperforms Sector by 7.87 Percentage Points
2026-04-15 11:31:08The Sensex advanced 1.44% on 15 Apr 2026, yet Innova Captab Ltd outpaced the broader market with an 8.29% gain, reaching an intraday peak of Rs 751.45. This 7.87-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read full news articleCorporate Actions
07 May 2026
Innova Captab Ltd has declared 20% dividend, ex-date: 30 Jan 26
No Splits history available
No Bonus history available
No Rights history available








